Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bon Natural Life (BON) Receivables (2020 - 2025)

Bon Natural Life (BON) has disclosed Receivables for 6 consecutive years, with $11.5 million as the latest value for Q3 2025.

  • Quarterly Receivables fell 2.32% to $11.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $11.5 million through Sep 2025, down 2.32% year-over-year, with the annual reading at $11.5 million for FY2025, 2.32% down from the prior year.
  • Receivables for Q3 2025 was $11.5 million at Bon Natural Life, down from $11.8 million in the prior quarter.
  • The five-year high for Receivables was $16.2 million in Q3 2022, with the low at $4.6 million in Q3 2023.
  • Average Receivables over 5 years is $12.1 million, with a median of $11.8 million recorded in 2024.
  • The sharpest move saw Receivables soared 175.46% in 2021, then crashed 71.43% in 2023.
  • Over 5 years, Receivables stood at $16.2 million in 2021, then increased by 0.21% to $16.2 million in 2022, then crashed by 71.43% to $4.6 million in 2023, then surged by 155.51% to $11.8 million in 2024, then decreased by 2.32% to $11.5 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $11.5 million, $11.8 million, and $4.6 million for Q3 2025, Q3 2024, and Q3 2023 respectively.